Skip to main content
AAN.com
Articles
October 22, 2002

Acute disseminated encephalomyelitis
A long-term follow-up study of 84 pediatric patients

October 22, 2002 issue
59 (8) 1224-1231

Abstract

Background: Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the CNS. Few pediatric series have been published, with retrospective and short-term follow-up studies. Objectives: To describe a cohort of pediatric patients with ADEM and to determine whether clinical and neuroimaging findings predict outcome.
Methods: A prospective study was conducted between March 1988 and July 2000 on 84 consecutive children with ADEM at the National Pediatric Hospital “Dr. J. P. Garrahan.”
Results: Mean age at onset was 5.3 ± 3.9 years, with a significant male predominance. Sixty-two patients (74%) had a preceding viral illness or vaccination. Acute hemiparesis (76%), unilateral or bilateral long tract signs (85%), and changes in mental state (69%) were the most prominent presenting features. Four MRI groups were identified: ADEM with small lesions (62%), with large lesions (24%), with additional bithalamic involvement (12%), and acute hemorrhagic encephalomyelitis (2%). Of the 54 children whose CSF samples were analyzed, none showed intrathecal oligoclonal bands. The use of high-dose corticosteroid treatment, particularly IV methylprednisolone, was associated with good recovery and resolution of MRI lesions. After a mean follow-up of 6.6 ± 3.8 years, 90% of children showed a monophasic course, and 10% a biphasic disease. Eighty-nine percent of patients show at present Expanded Disability Status Scale scores of 0 to 2.5. Eleven percent have disability scores of 3 to 6.5.
Conclusions: Childhood acute disseminated encephalomyelitis is a benign condition, affecting boys more frequently. No association was found between MRI groups and disability. Disability was related to optic nerve involvement at presentation. Even in relapsing cases, the distinction between acute disseminated encephalomyelitis and MS was possible on the basis of long-term clinical and neuroimaging follow-up and the absence of oligoclonal bands in CSF.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
van der Knaap MS, Valk J. Acute disseminated encephalomyelitis and acute hemorrhagic encephalomyelitis. In: van der Knaap MS, Valk J, eds. Magnetic resonance of myelin, myelination and myelin disorders, 2nd ed. Berlin-Heidelberg: Springer-Verlag, 1995: 320–326.
2.
Rust RS. Multiple sclerosis, acute disseminated encephalomyelitis and related conditions. Semin Pediatr Neurol . 2000; 7: 66–90.
3.
Tenembaum S, Fejerman N. Enfermedades desmielinizantes. In: Fejerman N, Fernandez Alvarez E, eds. Neurología pediátrica, 2nd ed. Buenos Aires: Panamericana, 1997: 929–940.
4.
Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology . 2001; 56: 1308–1312.
5.
Tenembaum S, Galicchio S, Grañana N, Ferrea M, Chamoles N, Fejerman N. Multiphasic disseminated encephalomyelitis and multiple sclerosis in children: diagnostic clues. J Neurol Sci . 1997; 150 (suppl): S230.Abstract.
6.
Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain . 2000; 123: 2407–2422.
7.
Hindley DT, Newton RW, Clarke MA, et al. Steroid-responsive relapsing encephalopathy presenting in young children. Neuropediatrics . 1993; 24: 182.Abstract.
8.
Hartung HP, Grossman RI. ADEM: distinct disease or part of the MS spectrum? Neurology . 2001; 56: 1257–1260.
9.
Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology . 1994; 36: 216–220.
10.
Zeman A, McLean B, Keir G, Luxton R, Sharief M, Thompson E. The significance of serum oligoclonal bands in neurological diseases. J Neurol Neurosurg Psychiatry . 1993; 56: 32–35.
11.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology . 1983; 33: 1444–1452.
12.
Hung KL, Liao HT, Tsai ML. The spectrum of postinfectious encephalomyelitis. Brain Dev . 2001; 23: 42–45.
13.
Poser CM, Goutières F, Carpentier MA, Aicardi J. Schilder’s myelinoclastic diffuse sclerosis. Pediatrics . 1986; 77: 107–112.
14.
Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between MS and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol . 1993; 33: 18–27.
15.
Tenembaum S, Galicchio S, Grañana N, et al. Demyelinating encephalopathies with large focal lesions: diagnostic clues. Brain Dev . 1998; 20: 434.Abstract.
16.
Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotizing encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry . 1995; 58: 555–561.
17.
Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev . 1997; 19: 81–92.
18.
Suwa K, Yamagata T, Momoi MT, et al. Acute relapsing encephalopathy mimicking acute necrotizing encephalopathy in a 4-year-old boy. Brain Dev . 1999; 21: 554–558.
19.
Marcu H, Hacker H, Vonofakos D. Bilateral reversible thalamic lesions on computed tomography. Neuroradiology . 1979; 18: 201–204.
20.
Cusmai R, Bertini E, Di Capua M, et al. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics . 1994; 25: 44–47.
21.
Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics . 1998; 101: 112–119.
22.
Prabhakar S, Kurien E, Gupta RS, et al. Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology . 1994; 44: 1644–1648.
23.
Shoji H, Kusuhara T, Honda Y, et al. Relapsing acute disseminated encephalomyelitis associated with chronic Epstein-Barr virus infection: MRI findings. Neuroradiology . 1992; 34: 340–342.
24.
Khan S, Yaqub BA, Poser CM, Al Deeb SM, Bohlega S. Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia. J Neurol Neurosurg Psychiatry . 1995; 58: 467–470.
25.
Tsai ML, Hung KL. Multiphasic disseminated encephalomyelitis mimicking multiple sclerosis. Brain Dev . 1996; 18: 412–414.
26.
Revel-Vilk S, Hurvitz H, Klar A, Virozov Y, Korn-Lubetzki I. Recurrent acute disseminated encephalomyelitis associated with acute cytomegalovirus and Epstein-Barr virus infection. J Child Neurol . 2000; 15: 421–424.
27.
Poser CM. The epidemiology of multiple sclerosis: a general overview (review). Ann Neurol . 1994; 36 (suppl 2): S180–193.
28.
Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology . 1996; 46: 1173–1174.
29.
Apak RA, Anlar B, Saatci I. A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev . 1999; 21: 279–282.
30.
Mc Donald WI, Compston DAS, Edan G, et al. Recommended diagnostic criteria in multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol . 2001; 50: 121–127.
31.
Pasternak JF, De Vivo DC, Prensky AL. Steroid-responsive encephalomyelitis in childhood. Neurology . 1980; 30: 481–486.
32.
Straub J, Chofflon M, Delavelle J. Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology . 1997; 49: 1145–1147.
33.
Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis: clinical and immunologic studies. N Engl J Med . 1984; 310: 137–141.
34.
Epperson LW, Whitaker JN, Kapila A. Cranial MRI in acute disseminated encephalomyelitis. Neurology . 1988; 38: 332–333.
35.
Hurst EW. Acute hemorrhagic leukoencephalitis: a previously undefined entity. Med J Aust . 1941; 1: 1–6.
36.
Seales D, Greer M. Acute hemorrhagic leukoencephalitis: a successful recovery. Arch Neurol . 1991; 48: 1086–1088.
37.
Rosman PN, Gottlieb SM, Bernstein CA. Acute hemorrhagic leukoencephalitis: recovery and reversal of magnetic resonance imaging findings in a child. J Child Neurol . 1997; 12: 448–454.
38.
Klein C, Wijdicks EFM, Earnest IVF. Full recovery after acute hemorrhagic leukoencephalitis (Hurst’s disease). J Neurol . 2000; 247: 977–979.

Information & Authors

Information

Published In

Neurology®
Volume 59Number 8October 22, 2002
Pages: 1224-1231
PubMed: 12391351

Publication History

Received: October 24, 2001
Accepted: July 1, 2002
Published online: October 22, 2002
Published in print: October 22, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Silvia Tenembaum, MD
From the Department of Neurology (Drs. Tenembaum and Fejerman), Hospital Nacional de Pediatría “Dr. J. P. Garrahan” and Laboratory of Neurochemistry (Dr. Chamoles), Buenos Aires, Argentina.
Nestor Chamoles, MD
From the Department of Neurology (Drs. Tenembaum and Fejerman), Hospital Nacional de Pediatría “Dr. J. P. Garrahan” and Laboratory of Neurochemistry (Dr. Chamoles), Buenos Aires, Argentina.
Natalio Fejerman, MD
From the Department of Neurology (Drs. Tenembaum and Fejerman), Hospital Nacional de Pediatría “Dr. J. P. Garrahan” and Laboratory of Neurochemistry (Dr. Chamoles), Buenos Aires, Argentina.

Notes

Address correspondence and reprint requests to Dr. Silvia Tenembaum, Department of Neurology, Hospital de Pediatría Dr. J. P. Garrahan, Combate de los Pozos 1881 (1245), Buenos Aires, Argentina. e-mail: [email protected]; [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Pediatric acquired brain injury, Capute and Accardo' s Neurodevelopmental Disabilities in Infancy and Childhood, (247-272), (2025).https://doi.org/10.1016/B978-0-12-824060-1.00052-3
    Crossref
  2. Evaluating Therapeutic Plasma Exchange in Pediatric Acute Disseminated Encephalomyelitis: A Comprehensive Review, Cureus, (2024).https://doi.org/10.7759/cureus.64190
    Crossref
  3. Clinical Profile and Outcome of Pediatric Demyelinating Disorders in Calabar, Nigeria: A Case Series, Nigerian Journal of Clinical Practice, 27, 6, (696-701), (2024).https://doi.org/10.4103/njcp.njcp_155_23
    Crossref
  4. Acquired Demyelination Syndrome in Children and Adolescents: 10 Years Experience from a Tertiary Care Centre in North India, Neurology India, 72, 5, (997-1002), (2024).https://doi.org/10.4103/neurol-india.NI_1141_20
    Crossref
  5. Acute Hemorrhagic Leukoencephalitis with Concurrent Retinal Vasculitis in an Elderly Japanese Patient: A Case Report, Internal Medicine, (2024).https://doi.org/10.2169/internalmedicine.3518-24
    Crossref
  6. Emergent Management of Central Nervous System Demyelinating Disorders, CONTINUUM: Lifelong Learning in Neurology, 30, 3, (781-817), (2024).https://doi.org/10.1212/CON.0000000000001436
    Crossref
  7. Multimodal evoked potentials are useful for the diagnosis of pediatric acute disseminated encephalomyelitis, BMC Pediatrics, 24, 1, (2024).https://doi.org/10.1186/s12887-024-04576-7
    Crossref
  8. Cognitive and psychopathological outcomes in acute disseminated encephalomyelitis, BMJ Neurology Open, 6, 1, (e000640), (2024).https://doi.org/10.1136/bmjno-2024-000640
    Crossref
  9. Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders, European Journal of Paediatric Neurology, 50, (86-95), (2024).https://doi.org/10.1016/j.ejpn.2024.04.011
    Crossref
  10. Etiologies and clinical characteristics of acute ataxia in a single national children's medical center, Brain and Development, 46, 2, (103-107), (2024).https://doi.org/10.1016/j.braindev.2023.10.005
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share